General Services Administration (GSA)
6
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
16.7%
1 terminated/withdrawn out of 6 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
50%
2 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Blood Glucose Monitoring in Electronic Health Records
Role: collaborator
The Effect of Informative Letters on the Prescription and Receipt of Schedule II Controlled Substances
Role: collaborator
The Effect of Informative Letters on the Prescription and Receipt of Opioids
Role: collaborator
The Effect of Informative Letters on the Prescription and Receipt of Seroquel
Role: collaborator
Reducing Concurrent Opioid-Benzodiazepine Prescriptions
Role: collaborator
Increasing Vaccine Uptake Among Veterans at the Atlanta VA Health Care System
Role: collaborator
All 6 trials loaded